Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Scientists at Pfizer describe a novel series of PDE9 inhibitors

Dec. 21, 2004

Positive data from ongoing studies of rhC1INH for hereditary angioedema

Dec. 21, 2004

Preclinical effects of the novel thrombopoietin receptor agonist, SB-559457, on hematopoietic cells

Dec. 21, 2004

TAP submits febuxostat NDA for management of hyperuricemia in gout

Dec. 20, 2004

Diamyd to be tested in type 1 diabetes

Dec. 20, 2004

New insulin secretagogues and their use covered in recent patent

Dec. 16, 2004

First data reported on the effects of PBI-1402 on red blood cell production in humans

Dec. 16, 2004

Phase II study confirms the therapeutic benefits of AOD-9604 in obesity

Dec. 16, 2004

A series of spiropiperidine derivatives presented by Merck & Co.

Dec. 15, 2004

PSK-3471: a novel SERM prevents bone loss and restores bone mass in rodents/News in Context

Dec. 15, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...